Last reviewed · How we verify
NCT03914313
Robotics Plus VR in Improving Cognition
NA trial testing Robotic Treatment plus VR in Cognition Disorders in 90 participants. Completed in 31 December 2019.
10 November 2019
Quick facts
| Lead sponsor | IRCCS Centro Neurolesi Bonino Pulejo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 23 April 2019 |
| Primary completion | 10 November 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Robotic Treatment plus VR
Conditions studied
- Cognition Disorders — all drugs for Cognition Disorders →
Sponsor
IRCCS Centro Neurolesi Bonino Pulejo — full company profile →
Who can join
Adults 40 to 75, any sex, with Cognition Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Stroke can be classified as ischemic, i.e. due to the lack of blood flow, and haemorrhagic, caused by bleeding. Stroke results in focal signs and symptoms, with a devastating impact on a patient and his family. Although robotic rehabilitation is very useful in improving motor function, there is no a clear evidence on its role in improving cognitive abilities, which are often compromised in stroke patients. To this end, the investigators designed a randomized controlled experimental study on stroke patients, with the aim of evaluating the effects of robotic neurorehabilitation using Lokomat with and without virtual reality on cognitive functioning in stroke patients, compared to traditional therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03914313
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognition Disorders
Currently open trials in the same condition.
- NCT07526740 — Brain Stimulation and Cognitive Training for MCI · NA · recruiting
- NCT06836440 — Impact of Glasses for Vision Problems on Cognitive Function in Rural Older Adults · NA · recruiting
Other IRCCS Centro Neurolesi Bonino Pulejo trials
Trials by the same sponsor.
- NCT07385508 — Neurorehabilitation in Patients With Disorders of Consciousness: Multidimensional Ambispective Study on the Impact of Si · not yet recruiting
- NCT07358962 — Mild Cognitive Impairment and Psychopathology · not yet recruiting
- NCT07321080 — Central Sensitisation in Nociceptive and Neuropathic Pain · active not recruiting
- NCT07268768 — PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE · recruiting
- NCT07422324 — Multidimensional Assessment of Mental Health in Adolescence. · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03914313 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Centro Neurolesi Bonino Pulejo
- Last refreshed: 22 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03914313.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing